Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DFMO inhibition of neuroblastoma tumorigenesis.
Gandra D, Mulama DH, Foureau DM, McKinney KQ, Kim E, Smith K, Haw J, Nagulapally A, Saulnier Sholler GL. Gandra D, et al. Among authors: foureau dm. Cancer Med. 2024 May;13(9):e7207. doi: 10.1002/cam4.7207. Cancer Med. 2024. PMID: 38686627 Free PMC article.
Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer.
Eisner JR, Beebe KD, Mayhew GM, Shibata Y, Guo Y, Farhangfar C, Farhangfar F, Uronis JM, Mooney J, Milburn MV, Foureau D, White RL, Amin A, Milla ME. Eisner JR, et al. Cancer Res Commun. 2022 Aug 30;2(8):894-903. doi: 10.1158/2767-9764.CRC-21-0153. eCollection 2022 Aug. Cancer Res Commun. 2022. PMID: 36923304 Free PMC article.
Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma.
Livingston MB, Jagosky MH, Robinson MM, Ahrens WA, Benbow JH, Farhangfar CJ, Foureau DM, Maxwell DM, Baldrige EA, Begic X, Symanowski JT, Steuerwald NM, Anderson CJ, Patt JC, Kneisl JS, Kim ES. Livingston MB, et al. Among authors: foureau dm. Clin Cancer Res. 2021 Dec 1;27(23):6424-6431. doi: 10.1158/1078-0432.CCR-21-2001. Epub 2021 Sep 2. Clin Cancer Res. 2021. PMID: 34475102 Clinical Trial.
Extramedullary multiple myeloma.
Bhutani M, Foureau DM, Atrash S, Voorhees PM, Usmani SZ. Bhutani M, et al. Among authors: foureau dm. Leukemia. 2020 Jan;34(1):1-20. doi: 10.1038/s41375-019-0660-0. Epub 2019 Nov 27. Leukemia. 2020. PMID: 31776467 Review.
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies.
Beebe KD, Eisner JR, Guo J, Shibata Y, Davison JM, Uronis J, Farhangfar C, Farhangfar F, Mooney J, Milburn MV, White RL, Amin A, Milla ME, Foureau DM. Beebe KD, et al. Among authors: foureau dm. J Immunol. 2024 May 20:ji2300736. doi: 10.4049/jimmunol.2300736. Online ahead of print. J Immunol. 2024. PMID: 38767437
Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients.
Sanders JA, Frasier C, Matulay JT, Steuerwald NM, Zhu J, Grigg CM, Kearns JT, Riggs SB, Gaston KE, Brouwer CR, Burks RT, Hartman AL, Foureau DM, Burgess EF, Clark PE. Sanders JA, et al. Among authors: foureau dm. Transl Androl Urol. 2021 Jul;10(7):2998-3009. doi: 10.21037/tau-21-158. Transl Androl Urol. 2021. PMID: 34430403 Free PMC article.
Peripheral Immunotype Correlates with Minimal Residual Disease Status and Is Modulated by Immunomodulatory Drugs in Multiple Myeloma.
Bhutani M, Foureau D, Zhang Q, Robinson M, Wynn AS, Steuerwald NM, Druhan LJ, Guo F, Rigby K, Turner M, Slaughter D, Friend R, Atrash S, Symanowski JT, Avalos BR, Copelan EA, Voorhees PM, Usmani SZ. Bhutani M, et al. Biol Blood Marrow Transplant. 2019 Mar;25(3):459-465. doi: 10.1016/j.bbmt.2018.11.015. Epub 2018 Nov 24. Biol Blood Marrow Transplant. 2019. PMID: 30481597 Free article.
35 results